NUKK · Nukkleus Inc. - Financials
Annual line items from SEC XBRL filings, sourced from EDGAR's Company Facts API with fallback to the quarterly Financial Statement Data Sets. See issuer overview for Form 4 activity and 10-K signals.
Income Statement
| Line item | Q3 '23 | Q2 '23 | Q1 '23 | Q3 '22 | Q2 '22 | Q1 '22 | Q3 '21 | Q2 '21 | Q1 '21 | Q3 '20 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $5.21M | $5.63M | $5.38M | $5.15M | $5.09M | $5.13M | $4.80M | - | - | - |
| Cost of Revenue | $5.37M | $5.49M | $5.43M | $5.43M | $4.72M | $4.72M | $4.72M | - | - | - |
| Gross Profit | ($158.0K) | $148.0K | ($54.9K) | ($273.5K) | $200.4K | $243.2K | $89.0K | $75.0K | $75.0K | $75.0K |
| R&D | - | - | - | - | - | - | - | - | - | - |
| SG&A | - | - | - | - | - | - | - | - | - | - |
| Total Operating Expenses | $1.05M | $954.3K | $1.08M | $1.38M | $2.05M | $2.19M | $188.7K | $73.4K | $127.1K | $62.2K |
| D&A | $592.9K | $592.9K | $592.9K | $592.9K | $592.9K | $911.9K | $117.1K | - | - | - |
| Operating Income | ($1.21M) | ($806.4K) | ($1.14M) | ($1.65M) | ($1.85M) | ($1.94M) | ($99.7K) | $1.6K | ($52.1K) | $12.8K |
| Interest Expense | - | - | - | - | - | - | - | - | - | - |
| Income Tax | - | - | - | - | - | - | - | - | - | - |
| Net Income | ($1.21M) | ($805.6K) | ($1.13M) | ($1.99M) | ($1.93M) | ($1.94M) | ($100.5K) | $49 | ($53.6K) | $11.5K |
| EPS - Basic | $0.00 | $0.00 | $0.00 | ($0.01) | ($0.01) | $0.00 | $0.00 | $0.00 | - | $0.00 |
| EPS - Diluted | $0.00 | $0.00 | $0.00 | ($0.01) | ($0.01) | $0.00 | $0.00 | $0.00 | - | $0.00 |
Balance Sheet
| Line item | Q3 '23 | Q2 '23 | Q1 '23 | Q3 '22 | Q2 '22 | Q1 '22 | Q3 '21 | Q2 '21 | Q1 '21 | Q3 '20 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $142.3K | $246.7K | $279.7K | $364.0K | $50.4K | $50.6K | $355.7K | $99.5K | $90.3K | $82.8K |
| Accounts Receivable | - | - | - | $68.5K | $55.9K | $55.8K | $58.0K | - | - | - |
| Inventory | - | - | - | - | - | - | - | - | - | - |
| Accounts Payable | $106.8K | $82.3K | $55.4K | $51.7K | $110.0K | $97.4K | $54.8K | - | - | - |
| Current Assets | $2.41M | $1.41M | $9.71M | $3.69M | $1.61M | $2.73M | $3.04M | $3.02M | $3.51M | $3.80M |
| Total Assets | $15.35M | $14.94M | $23.79M | $18.36M | $22.40M | $19.18M | $16.66M | $3.02M | $3.51M | $3.80M |
| Current Liabilities | $7.36M | $5.80M | $13.92M | $7.47M | $4.59M | $4.98M | $4.64M | $4.47M | $4.96M | $5.19M |
| Long-term Debt | - | - | - | - | - | - | - | - | - | - |
| Total Liabilities | $7.36M | $5.80M | $13.92M | $7.47M | $4.59M | $4.98M | $4.64M | $4.47M | $4.96M | $5.19M |
| Stockholders' Equity | $7.99M | $9.14M | $9.88M | $10.89M | $17.82M | $14.19M | $12.02M | ($1.45M) | ($1.45M) | ($1.39M) |
| Retained Earnings | ($17.49M) | ($16.28M) | ($15.47M) | ($14.34M) | ($6.37M) | ($4.44M) | ($2.50M) | ($1.61M) | ($1.61M) | ($1.56M) |
Cash Flow
| Line item | Q3 '23 | Q2 '23 | Q1 '23 | Q3 '22 | Q2 '22 | Q1 '22 | Q3 '21 | Q2 '21 | Q1 '21 | Q3 '20 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | $5.83M | - | - | ($305.3K) | - | - | $7.5K | - |
| Investing Cash Flow | - | - | ($67.8K) | - | - | - | - | - | - | - |
| Financing Cash Flow | - | - | - | - | - | - | - | - | - | - |
| CapEx | - | - | - | - | - | - | - | - | - | - |
| Free Cash Flow | - | - | - | - | - | - | - | - | - | - |
Ratios
| Metric | Q3 '23 | Q2 '23 | Q1 '23 | Q3 '22 | Q2 '22 | Q1 '22 | Q3 '21 | Q2 '21 | Q1 '21 | Q3 '20 |
|---|---|---|---|---|---|---|---|---|---|---|
| Profitability | ||||||||||
| Gross margin | -3.0% | 2.6% | -1.0% | -5.3% | 3.9% | 4.7% | 1.9% | - | - | - |
| Operating margin | -23.3% | -14.3% | -21.1% | -32.1% | -36.4% | -37.9% | -2.1% | - | - | - |
| EBITDA margin | -11.9% | -3.8% | -10.1% | -20.6% | -24.8% | -20.1% | 0.4% | - | - | - |
| Net margin | -23.2% | -14.3% | -21.1% | -38.6% | -37.9% | -37.9% | -2.1% | - | - | - |
| Free cash flow margin | - | - | - | - | - | - | - | - | - | - |
| FCF / Net income | - | - | - | - | - | - | - | - | - | - |
| R&D / Revenue | - | - | - | - | - | - | - | - | - | - |
| SG&A / Revenue | - | - | - | - | - | - | - | - | - | - |
| Effective tax rate | - | - | - | - | - | - | - | - | - | - |
| Return on assets | -7.9% | -5.4% | -4.8% | -10.8% | -8.6% | -10.1% | -0.6% | 0.0% | -1.5% | 0.3% |
| Return on equity | -15.1% | -8.8% | -11.5% | -18.2% | -10.8% | -13.7% | -0.8% | -0.0% | 3.7% | -0.8% |
| Return on invested capital | - | - | - | - | - | - | - | - | - | - |
| Liquidity | ||||||||||
| Current ratio | 0.33 | 0.24 | 0.70 | 0.49 | 0.35 | 0.55 | 0.66 | 0.68 | 0.71 | 0.73 |
| Quick ratio | 0.33 | 0.24 | 0.70 | 0.49 | 0.35 | 0.55 | 0.66 | 0.68 | 0.71 | 0.73 |
| Cash ratio | 0.02 | 0.04 | 0.02 | 0.05 | 0.01 | 0.01 | 0.08 | 0.02 | 0.02 | 0.02 |
| Leverage | ||||||||||
| Debt / Equity | - | - | - | - | - | - | - | - | - | - |
| Debt / Assets | - | - | - | - | - | - | - | - | - | - |
| Debt / EBITDA | - | - | - | - | - | - | - | - | - | - |
| Interest coverage | - | - | - | - | - | - | - | - | - | - |
| Equity multiplier | 1.92 | 1.63 | 2.41 | 1.69 | 1.26 | 1.35 | 1.39 | -2.09 | -2.43 | -2.73 |
| Liabilities / Assets | 0.48 | 0.39 | 0.58 | 0.41 | 0.20 | 0.26 | 0.28 | 1.48 | 1.41 | 1.37 |
| Efficiency | ||||||||||
| Asset turnover | 0.34 | 0.38 | 0.23 | 0.28 | 0.23 | 0.27 | 0.29 | - | - | - |
| Inventory turnover | - | - | - | - | - | - | - | - | - | - |
| Days sales outstanding | - | - | - | 5d | 4d | 4d | 4d | - | - | - |
| Days inventory outstanding | - | - | - | - | - | - | - | - | - | - |
| Days payable outstanding | 7d | 5d | 4d | 3d | 8d | 8d | 4d | - | - | - |
| Cash conversion cycle | - | - | - | - | - | - | - | - | - | - |
| Valuation | ||||||||||
| P / E | - | - | - | - | - | - | - | - | - | - |
| P / B | - | - | - | - | - | - | - | - | - | - |
| P / S | - | - | - | - | - | - | - | - | - | - |
| EV / EBITDA | - | - | - | - | - | - | - | - | - | - |
| Growth | ||||||||||
| Revenue growth (YoY) | 1.2% | 10.7% | 4.8% | 7.3% | - | - | - | - | - | - |
| Revenue CAGR (3y) | - | - | - | - | - | - | - | - | - | - |
| Revenue CAGR (5y) | - | - | - | - | - | - | - | - | - | - |
| Gross profit growth (YoY) | 42.2% | -26.2% | - | - | 167.2% | 224.2% | 18.6% | 0.0% | 0.0% | 0.0% |
| Operating income growth (YoY) | 26.7% | 56.5% | 41.5% | -1558.7% | - | -3631.6% | - | - | 15.6% | - |
| Net income growth (YoY) | 39.1% | 58.2% | 41.7% | -1875.7% | - | -3528.8% | - | - | -18.3% | - |
| EPS growth (YoY) | - | - | - | - | - | - | - | - | - | - |
| EPS CAGR (3y) | - | - | - | - | - | - | - | - | - | - |
| EPS CAGR (5y) | - | - | - | - | - | - | - | - | - | - |
| FCF growth (YoY) | - | - | - | - | - | - | - | - | - | - |
| FCF CAGR (5y) | - | - | - | - | - | - | - | - | - | - |
| Book value growth (YoY) | -26.7% | -48.7% | -30.4% | -9.4% | - | - | - | -3.2% | -8.1% | -7.8% |
Sales by segment
From XBRL dimensional facts in the 10-K period ending 2021-09-30.
Business segments
$19.29M totalGeneral Support Services$19.20M · 99.5%
Financial Services$87.0K · 0.5%
Peer comparison
Same SIC group: Services-Management Consulting Services
Comparing Nukkleus Inc. against the 5 most active filers in the same SIC group.